Speaker
Chief Executive Officer, NurExone
Lior Shaltiel, Chief Executive Officer at NurExone, spoke at 8th Exosome-Based Therapeutics Development Summit (Boston, United States of America, 22–24 Sept 2026) in the session “Roundtable Discussion: Understanding Investor Perspectives on Exosome Therapeutics to Navigate Risk Reward Clinical Validation & Platform Scalability in a Growing Field”.
22–24 Sept 2026Boston, United States of America
Chief Technology Officer, Gefjon Pharma
Senior Director - International Business Development, Daicel Life Sciences
Senior Principal, Regenerative Medicine, Dark Horse Consulting Group
Research & Development Director, Neucore Bio
Hemato-Oncologist, Centro Oncologico de Antioquia
Chief Commercial Officer, NorthX Biologics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Lior Shaltiel, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].